News

A new drug combination could increase progression-free survival rates of metastatic colorectal cancer patients with a rare genetic tumor mutation.

Findings reveal the likely reason why certain chemotherapies are effective for many patients. Importantly, they also help explain why attempts to find new chemo drugs based solely on stopping cellular division have been so disappointing.

A new reactor the size of a minifridge that rapidly grows cancer-killing white blood cells could advance the availability of immunotherapy.

New research has identified that cerebrospinal fluid reduces treatment efficacy for brain cancer, but an anti-anxiety drug used since the 1950s could re-sensitize glioblastoma to chemotherapy.

Researchers have unpicked the mechanism behind how Kaposi's sarcoma herpesvirus reprograms immune cells, increasing inflammation and making an individual vulnerable to cancer development.

Inspired by the process cells use to assemble proteins, Johns Hopkins University researchers developed Raman-active self-assembling bioorthogonal enzyme recognition (nanoSABER) probes for targeted tumor imaging.

A form of computerised attention and memory training can improve impaired attention and memory issues in women treated for breast cancer, University of Reading researchers have found.

Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal models by disrupting several cancer-promoting pathways.

Oxford University Hospitals is now offering CAR-T therapies to people with cancer. The cutting-edge therapy, which uses a patient's own immune cells to create a tailored treatment.

Lung cancer cells that metastasize to the brain survive by convincing brain cells called astrocytes that they are baby neurons in need of protection, according to a study by researchers at Stanford Medicine.